CD82/Kai-1 Antibody (B-L2) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-18099IR
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunohistochemistry
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # B-L2
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
CD82 transfected P815 cell line. Hybridoma: Myeloma X63/AG.8653 x Balb/c spleen cells
Specificity
Recognizes the CD82 antigen, a 60 kDa protein. Cross reacts with mouse CD82 protein in cytometry.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for CD82/Kai-1 Antibody (B-L2) [DyLight 755]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD82/Kai-1
Alternate Names
CD82, IA4, KAI1, SAR2, ST6, TSPAN27
Gene Symbol
CD82
Additional CD82/Kai-1 Products
Product Documents for CD82/Kai-1 Antibody (B-L2) [DyLight 755]
Product Specific Notices for CD82/Kai-1 Antibody (B-L2) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...